CN115584341A - Fish myoblast differentiation culture medium and artificial fish tissue method - Google Patents
Fish myoblast differentiation culture medium and artificial fish tissue method Download PDFInfo
- Publication number
- CN115584341A CN115584341A CN202211387421.5A CN202211387421A CN115584341A CN 115584341 A CN115584341 A CN 115584341A CN 202211387421 A CN202211387421 A CN 202211387421A CN 115584341 A CN115584341 A CN 115584341A
- Authority
- CN
- China
- Prior art keywords
- fish
- dimensional
- culture
- culture medium
- myoblasts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 53
- 210000003098 myoblast Anatomy 0.000 title claims abstract description 32
- 230000004069 differentiation Effects 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 20
- 239000001963 growth medium Substances 0.000 title claims abstract description 10
- 239000002609 medium Substances 0.000 claims abstract description 31
- 210000004027 cell Anatomy 0.000 claims abstract description 28
- 235000013372 meat Nutrition 0.000 claims abstract description 26
- 210000003205 muscle Anatomy 0.000 claims abstract description 24
- 238000012136 culture method Methods 0.000 claims abstract description 8
- 210000001789 adipocyte Anatomy 0.000 claims abstract description 6
- LBPKYPYHDKKRFS-UHFFFAOYSA-N 1,5-naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]- Chemical compound CC1=CC=CC(C2=C(C=NN2)C=2N=C3C=CC=NC3=CC=2)=N1 LBPKYPYHDKKRFS-UHFFFAOYSA-N 0.000 claims description 22
- 108010010803 Gelatin Proteins 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 15
- 229920000159 gelatin Polymers 0.000 claims description 15
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims description 15
- 230000019491 signal transduction Effects 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical group CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 6
- 235000010413 sodium alginate Nutrition 0.000 claims description 6
- 239000000661 sodium alginate Substances 0.000 claims description 6
- 229940005550 sodium alginate Drugs 0.000 claims description 6
- 238000007639 printing Methods 0.000 claims description 5
- 238000004088 simulation Methods 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 239000002243 precursor Substances 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000003999 initiator Substances 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 238000007711 solidification Methods 0.000 claims description 2
- 230000008023 solidification Effects 0.000 claims description 2
- 238000013334 tissue model Methods 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 abstract description 14
- 108090001012 Transforming Growth Factor beta Proteins 0.000 abstract description 14
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract description 14
- 238000004113 cell culture Methods 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 description 39
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 14
- 230000004927 fusion Effects 0.000 description 11
- 102000014736 Notch Human genes 0.000 description 10
- 108010070047 Notch Receptors Proteins 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 239000012091 fetal bovine serum Substances 0.000 description 9
- 230000004070 myogenic differentiation Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 239000007640 basal medium Substances 0.000 description 6
- 241001596950 Larimichthys crocea Species 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000024245 cell differentiation Effects 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 210000001087 myotubule Anatomy 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 239000012192 staining solution Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102100036912 Desmin Human genes 0.000 description 2
- 108010044052 Desmin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000005045 desmin Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000010603 microCT Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000000651 myofibroblast Anatomy 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 102100035784 Decorin Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 1
- 101001000206 Homo sapiens Decorin Proteins 0.000 description 1
- 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
- 102100030590 Mothers against decapentaplegic homolog 6 Human genes 0.000 description 1
- 101710143114 Mothers against decapentaplegic homolog 6 Proteins 0.000 description 1
- 102100030608 Mothers against decapentaplegic homolog 7 Human genes 0.000 description 1
- 230000005913 Notch signaling pathway Effects 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101700026522 SMAD7 Proteins 0.000 description 1
- 102000004060 Transforming Growth Factor-beta Type II Receptor Human genes 0.000 description 1
- 108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 1
- 102000013814 Wnt Human genes 0.000 description 1
- 108050003627 Wnt Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000010201 enrichment analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- -1 hippo Proteins 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009753 muscle formation Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 210000002220 organoid Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000022379 skeletal muscle tissue development Effects 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于食品加工领域,尤其涉及一种鱼成肌细胞分化培养基及人造鱼肉组织方法。The invention belongs to the field of food processing, and in particular relates to a fish myoblast differentiation medium and a method for artificial fish tissue.
背景技术Background technique
近年来,基于对效率、可持续性、环境负担和动物福利的担忧,细胞培养肉技术已成为部分替代传统畜牧业肉类生产的替代品。组织样细胞培养肉,其成分和结构与真实肌肉组织相似,主要由脂肪细胞和排列的肌肉细胞组成,已在家禽牛和猪中成功开发。体外三维(3D)细胞培养条件,包括培养基(例如胎牛血清)和支撑材料,在以再生医学和类器官为目的的人类细胞或其他哺乳动物细胞培养物中已有大量研究。但是,食品构建的成本和规模以及其他关键方面(如目标物种、营养素和感官特征)与生物医学组织完全不同。对于细胞培养的肉类,建立自己的方法仍然面临许多难题。In recent years, cell-cultured meat technology has emerged as a partial alternative to traditional livestock meat production based on concerns about efficiency, sustainability, environmental burden, and animal welfare. Tissue-like cell-cultured meat, which is similar in composition and structure to real muscle tissue and consists mainly of fat cells and lined muscle cells, has been successfully developed in poultry cattle and pigs. In vitro three-dimensional (3D) cell culture conditions, including media (e.g., fetal bovine serum) and support materials, have been extensively studied in human or other mammalian cell cultures for regenerative medicine and organoid purposes. However, the cost and scale of food constructs, as well as other key aspects such as target species, nutrients, and sensory characteristics, are quite different from those of biomedical organizations. When it comes to cell-cultured meat, there are still many challenges to establishing your own methods.
细胞培养肉的生产是离体细胞(种子细胞)在适宜的培养环境中(培养基),如温度、氧气、营养物质和生长因子,通过增殖分化形成多核肌管,肌管成熟后形成肌肉纤维,最终成为一种模仿肉的产品。成肌细胞的分化极易受多种调节因子和信号通路影响,发生非预期性细胞命运分化,如细胞凋亡以及纤维样坏死等,导致细胞无法形成肌管,并进一步融合成为肌肉束。但现已知动物基因有上万个,且不同基因与信号通路之间的交互作用异常复杂,从中精准找到调控细胞分化行为的信号通路组合,进而使成肌细胞走向正确的分化命运是极大的挑战。The production of cell culture meat is that isolated cells (seed cells) form multinucleated myotubes through proliferation and differentiation in a suitable culture environment (medium), such as temperature, oxygen, nutrients and growth factors, and the myotubes mature to form muscle fibers , eventually becoming a product that mimics meat. The differentiation of myoblasts is highly susceptible to a variety of regulatory factors and signaling pathways, resulting in unintended cell fate differentiation, such as apoptosis and fibrous necrosis, resulting in the inability of cells to form myotubes and further fusion into muscle bundles. However, it is now known that there are tens of thousands of animal genes, and the interaction between different genes and signaling pathways is extremely complex. It is extremely important to accurately find the combination of signaling pathways that regulate cell differentiation behavior, and then make myoblasts move towards the correct differentiation fate. challenge.
细胞支架作为体外细胞三维组织培养中关键的一环,为成肌细胞和脂肪细胞增殖分化提供必要的附着体和载体。细胞培养肉中支架材料的选择既要满足绿色、安全、可食用的生产条件,又要符合细胞生物学特性(支持细胞黏附、增殖、迁移、分化)以及流变转化特性(低于细胞生长温度的凝固点、温和的交联方式、保护细胞的必要黏度)的需求。同时作为食用产品最终的一部分而言,其还要能够具备一定的机械强度,满足消费者对咀嚼性,粘弹性等口感的需求。这是横跨食品、生物、材料、机械等领域的高难度技术挑战。As a key part of three-dimensional tissue culture in vitro, cell scaffolds provide the necessary attachments and carriers for the proliferation and differentiation of myoblasts and adipocytes. The selection of scaffold materials in cell culture meat should not only meet the green, safe and edible production conditions, but also meet the biological characteristics of cells (supporting cell adhesion, proliferation, migration, differentiation) and rheological transformation characteristics (lower than cell growth temperature). Freezing point, mild cross-linking mode, necessary viscosity to protect cells). At the same time, as the final part of edible products, it must also have a certain mechanical strength to meet consumers' needs for chewiness, viscoelasticity and other textures. This is a difficult technical challenge across the fields of food, biology, materials, machinery and so on.
海鲜是许多人最喜欢的食物,含有丰富的蛋白质、ω-3脂肪酸和微量营养素。随着人口的增加,加上环境压力和气候变化,导致近几十年来对海洋食物资源过度开发,这对生态系统产生了巨大影响,因此,创新技术(例如:细胞培养鱼肉)是海鲜生产可持续性的迫切需要。目前虽然在哺乳动物(猪、牛、兔)中有一些类组织化培养肉的研究,但其与天然肉类结构仍有较大差距,多是采用一些简单堆叠的成型方式,其咀嚼性、弹性等尚无法和天然肉类媲美。由于缺乏鱼肌肉组织纹理特性和用于机械支撑的仿真3D支架,生产类组织质构的细胞培养鱼片仍然是一项未完成的任务。Seafood is a favorite food for many and is rich in protein, omega-3 fatty acids and micronutrients. As human population increases, coupled with environmental pressures and climate change, have led to the overexploitation of marine food resources in recent decades, which has had a huge impact on ecosystems, innovative technologies (e.g. cell cultured fish) are a viable option for seafood production. The urgent need for continuity. At present, although there are some researches on tissue cultured meat in mammals (pigs, cattle, rabbits), there is still a big gap between its structure and natural meat, and most of them adopt some simple stacking molding methods. Elasticity, etc. are still not comparable to natural meat. Producing cell-cultured fish fillets with tissue-like texture remains an unfinished task due to the lack of fish muscle tissue texture properties and realistic 3D scaffolds for mechanical support.
发明内容Contents of the invention
一方面,本发明通过转录组测序手段,从大量的信号通路中筛选出由Notch和TGF-β信号通路组合。并发现通过同时抑制Notch和TGF-β信号通路,能显著提高成肌细胞分化。On the one hand, the present invention screens out a combination of Notch and TGF-β signaling pathways from a large number of signaling pathways by means of transcriptome sequencing. And found that by simultaneously inhibiting Notch and TGF-β signaling pathways, it can significantly improve myoblast differentiation.
在本发明某些优选的实施例中,采用生长因子LY411575和RepSox对上述Notch和TGF-β信号通路实现抑制。数据表明,LY411575和RepSox的结合,无需借助其他生长因子的辅助,即可实现上述Notch和TGF-β信号通路的有效抑制,提高成肌细胞分化效率。In some preferred embodiments of the present invention, growth factors LY411575 and RepSox are used to inhibit the aforementioned Notch and TGF-β signaling pathways. The data show that the combination of LY411575 and RepSox can effectively inhibit the above-mentioned Notch and TGF-β signaling pathways without the assistance of other growth factors, and improve the differentiation efficiency of myoblasts.
在本发明某些优选的实施例中,所述LY411575浓度为1~20nM,RepSox的浓度是1~10μM。In some preferred embodiments of the present invention, the concentration of LY411575 is 1-20 nM, and the concentration of RepSox is 1-10 μM.
在本发明某些优选的实施例中,所述培养基为F12培养基。F12培养基为细胞分化过程提供能量补充,并协同LY411575和RepSox,促进细胞分化效率,增加肌管融合度。In some preferred embodiments of the present invention, the medium is F12 medium. F12 medium provides energy supplement for the cell differentiation process, and cooperates with LY411575 and RepSox to promote cell differentiation efficiency and increase myotube fusion.
作为本发明的另一方面,本发明提供一种成肌细胞的三维培养方法,该方法将成肌细胞和支架前驱体组成生物墨水,进行3D仿真打印,固化后采用上述培养基进行培养,得到三维肌肉组织。在三维体系下,成肌细胞在明胶基支架中三维生长,上述抑制Notch和TGF-β信号通路的培养基促进了鱼成肌细胞的肌源性分化,在3D体系下发挥了它独到的优势。通过实验证明,同样的培养基在三维体系下相比于二维体系,其分化促进率提高了9.79%。As another aspect of the present invention, the present invention provides a three-dimensional culture method of myoblasts. In this method, myoblasts and scaffold precursors are composed of bio-ink, and 3D simulation printing is performed. After curing, the above-mentioned medium is used for culture to obtain a three-dimensional muscle tissue. In a three-dimensional system, myoblasts grow three-dimensionally in a gelatin-based scaffold, and the above medium that inhibits Notch and TGF-β signaling pathways promotes the myogenic differentiation of fish myoblasts, and exerts its unique advantages in a 3D system . It has been proved by experiments that the differentiation promotion rate of the same medium in the three-dimensional system is increased by 9.79% compared with that in the two-dimensional system.
在本发明某些优选的实施例中,所述支架前驱体包括明胶,且生物墨水中明胶的浓度在5~10%。明胶可以为细胞黏附提供生物位点,增加细胞活性并为其生长提供生存空间。In some preferred embodiments of the present invention, the scaffold precursor includes gelatin, and the concentration of gelatin in the bio-ink is 5-10%. Gelatin can provide biological sites for cell adhesion, increase cell viability and provide living space for its growth.
在本发明某些优选的实施例中,所述生物墨水中,细胞浓度是1×106~1×107。In some preferred embodiments of the present invention, the cell concentration in the bio-ink is 1×10 6 -1×10 7 .
在本发明某些优选的实施例中,所述生物墨水中,还具有固化剂用于使明胶成型;固化后的明胶的硬度在9~14kPa。适宜的支架硬度有助于促进细胞贴壁,增加细胞活性并为其分化提供承载力。In some preferred embodiments of the present invention, the bio-ink also has a curing agent for shaping the gelatin; the hardness of the cured gelatin is 9-14 kPa. Appropriate scaffold stiffness helps to promote cell attachment, increase cell viability and provide bearing capacity for its differentiation.
在本发明某些优选的实施例中,所述的固化剂是海藻酸钠、壳聚糖,固化剂的固化通过固化引发剂实现,所述固化引发剂包括氯化钙、氯化钙、柠檬酸钠、氯化镁和氯化锌等。In some preferred embodiments of the present invention, described curing agent is sodium alginate, chitosan, and the curing of curing agent is realized by curing initiator, and described curing initiator comprises calcium chloride, calcium chloride, lemon Sodium Chloride, Magnesium Chloride and Zinc Chloride etc.
在本发明某些优选的实施例中,固化的浓度为0.1~5%,固化时间为1~10min。In some preferred embodiments of the present invention, the curing concentration is 0.1-5%, and the curing time is 1-10 minutes.
在本发明某些优选的实施例中,培养的条件为27℃,二氧化碳浓度5%。In some preferred embodiments of the present invention, the culture conditions are 27°C and 5% carbon dioxide concentration.
在本发明某些优选的实施例中,3D仿真打印是基于鱼肌组织模型进行打印,得到具有鱼肌组织结构的三维肌肉组织。具体的来说,对软组织进行染色,然后通过micro-CT扫描获取真实肉品二维切片图像,从而生成三维模型。In some preferred embodiments of the present invention, the 3D simulation printing is based on a fish muscle tissue model to obtain a three-dimensional muscle tissue with a fish muscle tissue structure. Specifically, the soft tissue is stained, and then micro-CT scans are used to obtain two-dimensional slice images of real meat to generate a three-dimensional model.
最后,本发明还涉及一种人造鱼肉组织成型方法,将鱼肉脂肪细胞填充至前述培养得到的肌肉组织中。相比于现有的堆叠方法,本方法更加简便,效率高,硬度、粘性、弹性、弹性等与天然鱼肌肉组织更加相似。Finally, the present invention also relates to a method for forming artificial fish flesh tissue, filling fish flesh fat cells into the aforementioned cultured muscle tissue. Compared with the existing stacking method, the method is simpler and more efficient, and its hardness, viscosity, elasticity, elasticity, etc. are more similar to natural fish muscle tissue.
本发明的有益效果在于:The beneficial effects of the present invention are:
(1)使用本发明中包含LY411575和RepSox的培养基,鱼成肌细胞二维分化效率从1%提高至32%,为后续肌肉组织的形成创造了良好的基础;(1) Using the medium containing LY411575 and RepSox in the present invention, the two-dimensional differentiation efficiency of fish myoblasts increased from 1% to 32%, creating a good foundation for the subsequent formation of muscle tissue;
(2)本发明中的明胶基细胞支架,对鱼细胞生物相容性优良,支持鱼细胞贴壁、增殖、分化,与本研究中包含LY411575和RepSox的分化培养基组合使用使鱼成肌细胞分化效率达到41.79%;(2) The gelatin-based cell scaffold in the present invention has excellent biocompatibility to fish cells, supports fish cell attachment, proliferation, and differentiation, and is used in combination with the differentiation medium containing LY411575 and RepSox in this study to make fish myoblasts The differentiation efficiency reached 41.79%;
(3)本发明人造鱼肉组织方法,能得到硬度、粘性、弹性、弹性等与天然鱼肉相似的细胞培养肉制品。(3) The artificial fish meat tissue method of the present invention can obtain cell culture meat products similar to natural fish meat in hardness, viscosity, elasticity, elasticity, etc.
附图说明Description of drawings
图1a为肌源性分化过程中的明场和免疫荧光图像(上为明场图,下为Dsemin染色后荧光显微镜观察图),b为肌源性分化过程中肌融合指数图(0天,3天,6天);Figure 1a is the bright field and immunofluorescence images during the myogenic differentiation process (the upper is the bright field image, the lower is the fluorescence microscope observation image after Dsemin staining), b is the muscle fusion index image during the myogenic differentiation process (0 day, 3 days, 6 days);
图2a为显示了第0天、第3天和第6天肌源分化期间所有差异表达基因的热图,b为显示了第0天和第3天之间差异表达基因的火山图,c为与第0天相比,第3天上调(红色条)和下调(蓝色条)的前10个富集Go分析,d为与肌肉形成相关的基因表达模式的热图,e为细胞周期相关基因的热图,f为Notch相关基因表达的热图,g为TGF-β相关基因表达的热图,h为肌纤维母细胞相关基因表达的热图,i为细胞外基质相关基因表达的热图,j为肌源性分化过程中差异基因富集分析图;Figure 2a is a heat map showing all differentially expressed genes during myogenic differentiation on
图3a为LY411575和RepSox单独及组合作用后的图像(上为显微镜明场图,下为Dsemin染色后荧光显微镜观察图),b为LY411575和RepSox单独及组合作用肌融合指数图;Figure 3a is the image of LY411575 and RepSox alone and in combination (upper is the bright field image of the microscope, and the lower is the image of fluorescence microscope observation after Dsemin staining), b is the muscle fusion index image of LY411575 and RepSox alone and in combination;
图4为LY411575和RepSox单独及组合作用对三维生长细胞的成肌效果影响图;Figure 4 is a graph showing the effect of LY411575 and RepSox alone and in combination on the myogenic effect of three-dimensional growing cells;
图5为细胞培养鱼肉与天然鱼肉的质构对比图。Figure 5 is a comparison of the texture of cell cultured fish meat and natural fish meat.
具体实施方式detailed description
为更进一步阐述本发明为实现预定发明目的所采取的技术手段及功效,以下结合附图及较佳实施例,对依据本发明的具体实施方式、结构、特征及其功效,详细说明如后。In order to further explain the technical means and effects of the present invention to achieve the intended purpose of the invention, the specific implementation, structure, features and effects of the present invention will be described in detail below in conjunction with the accompanying drawings and preferred embodiments.
实施例1Example 1
将黄鱼成肌细胞在孔板上培养至80%汇合度后,使用含有8%HS(马血清)、10ng/mL IGF-1、50nM坏死磺酰胺、200μM抗坏血酸(Phytotech,A106)、1×PS的F12培养基进行分化培养。分化效率如图1所示。从图1可以看出,在该分化培养基中培养的第3天,细长的肌管开始出现,第6天,在一些肌管中观察到类似骨骼肌的条纹(图1f)。Desmin(一种肌肉特异性蛋白)的免疫荧光染色显示,在第3天和第6天都检测到具有多个细胞核的Desmin阳性肌管(图1a)。而融合指数(多核肌管中的细胞核比例)在第3天(6.39%)高于第6天(1.30%)(图1b)。尽管第6天单个肌管中的平均核数较高,但第6天的肌管总数比第3天少得多,表明在3-6天成肌分化受到抑制。After the yellow croaker myoblasts were cultured to 80% confluence on the well plate, the cells containing 8% HS (horse serum), 10 ng/mL IGF-1, 50 nM necrotic sulfonamide, 200 μM ascorbic acid (Phytotech, A106), 1 × PS F12 medium for differentiation culture. Differentiation efficiency is shown in Figure 1. As can be seen from Figure 1, on
基于上述实验结果,本发明针对培养不同时间后的细胞(第0天、第3天、第6天)进行了差异表达基因分析,进一步通过KEGG分析,刷选出抑制成肌分化的信号通路,具体如下:Based on the above experimental results, the present invention analyzes the differentially expressed genes of cells cultured at different times (
(1)通过对第0天、第3天、第6天的RNA序列进行转录组学分析。聚类分析表明,与第0天相比,第3天的表达谱变化比第6天更剧烈(图2a),这与融合指数一致。差异表达基因(DEG)分析显示,从第0天到第3天,22093个基因中有1650个基因显著上调(log2 FC>1,FDR<0.05),1063个基因显著下调(log2 FC<-1,FDR<0.05)(图2b)。(1) By performing transcriptomic analysis on the RNA sequences of the 0th day, the 3rd day, and the 6th day. Cluster analysis showed that the expression profile changed more drastically on
(2)将上述差异表达基因进行KEGG通路注释后可以看出,许多重要的信号通路,包括MAPK、TGF-β、Wnt、Notch、hippo、HIF-1等,在差异表达基因中富集(图2d~i)。(2) After annotating the above differentially expressed genes with KEGG pathways, it can be seen that many important signaling pathways, including MAPK, TGF-β, Wnt, Notch, hippo, HIF-1, etc., are enriched in differentially expressed genes (Fig. 2d~i).
其中,与第0天相比,第3天,TGF-β信号传导的一些成员(dcn、tgffbr3、tmoda和smad3)的表达增加,而一些成员(smad6、smad2、tgfb1a、tgfb2和tgfbr1b)的表达减少;第6天,dcn、tgfbr2和smad7的表达增加,而smad6和smad2的表达减少。因此,低融合指数极有可能是由于TGF-β信号诱导的血清饥饿培养中成肌细胞转化为肌成纤维细胞所致。Among them, on
实施例2Example 2
本实施例中,旨在通过抑制TGF-β信号通路以及与肌源性分化相关的Notch信号通路,提高肌生成效率和预防肌纤维化。In this example, the purpose is to improve the efficiency of myogenesis and prevent myofibrosis by inhibiting the TGF-β signaling pathway and the Notch signaling pathway related to myogenic differentiation.
本实施例中,采用两种小分子药物:LY411575(一种Notch抑制剂)和RepSox(一种TGFβR-1/ALK5抑制剂)来实现上述两个信号通路的同步抑制。In this example, two small molecule drugs: LY411575 (a Notch inhibitor) and RepSox (a TGFβR-1/ALK5 inhibitor) were used to achieve simultaneous inhibition of the above two signaling pathways.
实验组(1):在基础培养基(含8%HS的F12培养基,1×PS)中加入10nMLY411575,5μMRepSox用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的常规培养。Experimental group (1): Add 10nMLY411575 and 5 μM RepSox to the basal medium (F12 medium containing 8% HS, 1×PS) for the cultivation of fish myoblasts for the first two days, and then transfer to DMEM medium (containing 8% FBS, 1×PS in DMEM) for routine culture in the later stage.
另外设对照组如下:In addition, a control group was set up as follows:
对照1:在基础培养基(含8%HS的F12培养基,1×PS)中加入10nMLY411575用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的常规培养。Control 1: 10 nMLY411575 was added to the basal medium (F12 medium containing 8% HS, 1 × PS) for the first two days of culture of fish myoblasts, and then transferred to DMEM medium (containing 8% FBS, 1 ×PS DMEM) for the later conventional culture.
对照2:在基础培养基(含8%HS的F12培养基,1×PS)中加入5μMRepSox用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的常规培养。Control 2: 5 μM RepSox was added to the basal medium (F12 medium containing 8% HS, 1 × PS) for the cultivation of fish myoblasts for the first two days, and then transferred to DMEM medium (containing 8% FBS, 1 × PS) ×PS DMEM) for the later conventional culture.
在DMEM中培养4天后的试验结果表明,对照组1和对照组2的肌管数量略有增加。而实验组(LY411575和RepSox同时添加),相比于对照组1和对照组2,肌管数量显著性增加(图3)。空白组的融合指数约为1%,通过RepSox或LY411575处理分别增加至8%和3.5%,实验组通过两种化学物质一起处理协同增加至32%。结果表明,通过同步抑制Notch和TGF-β信号,PSCs的成肌效率显著提高。可见,LY411575和RepSox的协同作用,除了他们各自发挥抑制Notch和TGF-β信号通路的作用下,还具有意想不到的技术效果。The test results after 4 days of culture in DMEM showed a slight increase in the number of myotubes in
实验组(2):在基础培养基(含8%HS的F12培养基,1×PS)中加入20nM LY411575,2μMRepSox用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的常规培养。Experimental group (2): 20nM LY411575 and 2 μM RepSox were added to the basal medium (F12 medium containing 8% HS, 1×PS) for the cultivation of fish myoblasts for the first two days, and then transferred to DMEM medium ( The later routine culture was carried out in DMEM containing 8% FBS and 1×PS.
实验组(3):在基础培养基(含10%HS的F12培养基,1×PS)中加入1nM LY411575,10μMRepSox用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有10%FBS、1×PS的DMEM)中进行后期的常规培养。Experimental group (3): Add 1nM LY411575 and 10μM RepSox to the basal medium (F12 medium containing 10% HS, 1×PS) for the cultivation of fish myoblasts for the first two days, and then transfer to DMEM medium ( The later conventional culture was carried out in DMEM containing 10% FBS and 1×PS.
实验组(4):在基础培养基(含6%HS的F12培养基,1×PS)中加入5nM LY411575,1μMRepSox用于鱼成肌细胞前两天的培养,然后转移到在DMEM培养基(含有6%FBS、1×PS的DMEM)中进行后期的常规培养。Experimental group (4): 5nM LY411575 and 1 μM RepSox were added to the basal medium (F12 medium containing 6% HS, 1×PS) for the cultivation of fish myoblasts for the first two days, and then transferred to the DMEM medium ( The later conventional culture was carried out in DMEM containing 6% FBS and 1×PS.
在DMEM中培养4天后,实验组2的肌细胞融合指数为16%;实验组3的肌细胞融合指数为21%。实验组4的肌细胞融合指数为14%。相比空白组和对照组的单独叠加,均有显著提升。After cultured in DMEM for 4 days, the muscle cell fusion index of
实施例3Example 3
本实施例旨在研究凝胶固化的条件,以筛选出适宜于细胞打印生长的三维骨架。This example aims to study the conditions of gel solidification to screen out a three-dimensional framework suitable for cell printing and growth.
(1)将10wt%鱼明胶、1wt%海藻酸钠和鱼成肌细胞混合,细胞浓度为1×106/mL,4℃冷却5min,后浸泡入1%CaCl2固化10分钟。此条件下水凝胶硬度为9kPa。培养5天后,细胞贴壁率为80.69%。说明细胞活力较高,为后续细胞分化成型提供了有利的生长条件。(1) Mix 10wt% fish gelatin, 1wt% sodium alginate and fish myoblasts at a cell concentration of 1×10 6 /mL, cool at 4°C for 5 minutes, and then soak in 1% CaCl 2 for 10 minutes to solidify. Under this condition, the hardness of the hydrogel is 9kPa. After culturing for 5 days, the cell adhesion rate was 80.69%. It shows that the cell viability is high, which provides favorable growth conditions for the subsequent cell differentiation and formation.
(2)将10wt%鱼明胶、1wt%海藻酸钠和鱼成肌细胞混合,细胞浓度为5×106/mL,4℃冷却5min,后浸泡入5%CaCl2固化10分钟。此条件下水凝胶硬度为21kPa。培养5天后,细胞贴壁率仅为9%。大部分细胞均已死亡,无法后续培养出组织。(2) Mix 10wt% fish gelatin, 1wt% sodium alginate and fish myoblasts at a cell concentration of 5×10 6 /mL, cool at 4°C for 5 minutes, and then soak in 5% CaCl 2 for 10 minutes to solidify. Under this condition, the hardness of the hydrogel is 21kPa. After 5 days of culture, the cell adhesion rate was only 9%. Most of the cells are dead, making it impossible to grow tissue later.
(3)将5wt%鱼明胶、1wt%海藻酸钠和鱼成肌细胞混合,4℃冷却5min,细胞浓度为1×107/mL,后浸泡入5%CaCl2固化5分钟。此条件下水凝胶硬度为14kPa。培养5天后,细胞贴壁率为51%。说明细胞活力尚可,仍具备使细胞生长的基本条件。(3) Mix 5wt% fish gelatin, 1wt% sodium alginate and fish myoblasts, cool at 4°C for 5 minutes, the cell concentration is 1×10 7 /mL, and then soak in 5% CaCl 2 for 5 minutes to solidify. Under this condition, the hardness of the hydrogel is 14kPa. After culturing for 5 days, the cell adhesion rate was 51%. It shows that the cell viability is acceptable, and the basic conditions for cell growth are still available.
可见,固化后的凝胶需要保持在9~14kPa,才能保证鱼成肌细胞的生长。本领域技术人员可以调控凝胶和固化剂的浓度,得到上述事宜细胞生长的力学环境。It can be seen that the cured gel needs to be kept at 9-14kPa to ensure the growth of fish myoblasts. Those skilled in the art can adjust the concentration of gel and curing agent to obtain the mechanical environment for cell growth in the above matters.
实施例4Example 4
(1)将黄鱼肉品样品于组织固定液中固定24h,固定完成后取出样品使用生理盐水洗涤,称重并使用染色液进行染色。染色完成后,使用75%酒精洗去表面附着的染色液,进行CT扫描;其中,染色液为:将10g碘化钾溶解于少量蒸馏水中,加入5g碘搅拌使碘完全溶解,继续加入蒸馏水使蒸馏水体积为100ml,即可得到3.75%的IKI溶液。(1) The yellow croaker meat samples were fixed in tissue fixative for 24 hours. After the fixation, the samples were taken out and washed with saline, weighed and stained with staining solution. After the dyeing is completed, use 75% alcohol to wash off the staining solution attached to the surface, and perform CT scanning; wherein, the staining solution is: dissolve 10g of potassium iodide in a small amount of distilled water, add 5g of iodine and stir to completely dissolve the iodine, continue to add distilled water to make the volume of the distilled water For 100ml, a 3.75% IKI solution can be obtained.
(2)利用SkyScan1272型号micro-CT设备对上述测试样品以3μm/pixel的分辨率进行扫描,获取有关三文鱼肌肉微观结构的连续二维切片图像。(2) Scan the above-mentioned test sample with a resolution of 3 μm/pixel by using SkyScan1272 micro-CT equipment to obtain continuous two-dimensional slice images of salmon muscle microstructure.
(3)使用Gaussian Filter对扫描得到的二维数据进行滤波处理;使用VolumeRendering对数据集进行初步三维渲染并通过Crop Editor将数据裁剪至合适大小;通过Interactive Thresholding对数据进行动态阈值分割,确定了各组分的阈值分布,对肌纤维的进行提取。(3) Use Gaussian Filter to filter the scanned two-dimensional data; use VolumeRendering to perform preliminary three-dimensional rendering of the data set and use Crop Editor to cut the data to an appropriate size; use Interactive Thresholding to perform dynamic threshold segmentation on the data to determine each Threshold distribution of components for extraction of muscle fibers.
(4)在不影响纤维主体的前提下,通过Image Segmentation对小尺度噪点进行去除,对小尺度空洞进行填补;使用Separate Objects对相邻肌纤维进行分割;使用GenerateSurface对三维模型表面进行平滑处理,以.stl格式导出得到三维模型。(4) Under the premise of not affecting the main body of the fiber, use Image Segmentation to remove small-scale noise and fill small-scale cavities; use Separate Objects to segment adjacent muscle fibers; use GenerateSurface to smooth the surface of the 3D model to Export the 3D model in .stl format.
(5)将10wt%鱼明胶、1wt%海藻酸钠和鱼成肌细胞混合后,细胞浓度是5×106/mL,使用上述生成的.stl格式模型进行3D打印,即得黄鱼仿真肌肉支架。(5) After mixing 10wt% fish gelatin, 1wt% sodium alginate and fish myoblasts, the cell concentration is 5×10 6 /mL, use the .stl format model generated above for 3D printing, and obtain the yellow croaker simulation muscle scaffold .
(6)将支架置于添加了10nMLY411575和5μMRepSox的培养基(含8%HS的F12培养基,1×PS)培养两天,而后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的培养,培养5天后得到肌肉组织。观察其分化效果,融合指数达到了41.79%。相较于实例2中2维环境下的分化效果,提升了9.79%。(6) Place the scaffold in the culture medium (F12 medium containing 8% HS, 1×PS) supplemented with 10 nMLY411575 and 5 μM RepSox for two days, and then transfer to DMEM medium (containing 8% FBS, 1×PS DMEM) for the later stage of culture, and obtained muscle tissue after 5 days of culture. Observing its differentiation effect, the fusion index reached 41.79%. Compared with the differentiation effect in the 2-dimensional environment in Example 2, it has increased by 9.79%.
另外,将步骤5得到的支架置于单独添加了LY411575的培养基(含8%HS的F12培养基,1×PS)培养两天,而后转移到在DMEM培养基(含有8%FBS、1×PS的DMEM)中进行后期的常规培养。培养7天后观察其分化效果,在材料和分化培养基的协同作用下,融合指数为13.6%。In addition, the scaffold obtained in
可见,在三维体系下,LY411575和RepSox的协效作用尤为显著。It can be seen that in the three-dimensional system, the synergistic effect of LY411575 and RepSox is particularly significant.
实施例5Example 5
将分化后的鱼肉脂肪细胞填充实施例4步骤6培养得到的肌肉组织中。对比了本方法所得到的细胞培养鱼肉与天然黄鱼质构上的差异,结果如图5所示。培养鱼肉的硬度为5.37±0.42N,与天然黄鱼片的硬度范围相同(5.72±0.80N)。培养的肉和天然肌肉组织在粘性、弹性和弹性方面也没有明显差异。说明本方法构建的细胞培养鱼肉成型效率高,且质构与真实鱼肉更加接近,优于目前的组装拼接式构建类组织细胞培养肉的方法。The differentiated fish adipocytes were filled into the muscle tissue cultured in
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭示如上,然而并非用以限定本发明,任何本领域技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的技术内容做出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简介修改、等同变化与修饰,均仍属于本发明技术方案的范围内。The above description is only a preferred embodiment of the present invention, and does not limit the present invention in any form. Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone skilled in the art , without departing from the scope of the technical solution of the present invention, when the technical content disclosed above can be used to make some changes or be modified into equivalent embodiments with equivalent changes, but as long as it does not depart from the technical solution of the present invention, the technical content of the present invention In essence, any brief modifications, equivalent changes and modifications made to the above embodiments still fall within the scope of the technical solution of the present invention.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211387421.5A CN115584341A (en) | 2022-11-07 | 2022-11-07 | Fish myoblast differentiation culture medium and artificial fish tissue method |
PCT/CN2022/133749 WO2024098467A1 (en) | 2022-11-07 | 2022-11-23 | Fish myoblast differentiation culture medium and method for preparing artificial fish tissue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211387421.5A CN115584341A (en) | 2022-11-07 | 2022-11-07 | Fish myoblast differentiation culture medium and artificial fish tissue method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115584341A true CN115584341A (en) | 2023-01-10 |
Family
ID=84782328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211387421.5A Pending CN115584341A (en) | 2022-11-07 | 2022-11-07 | Fish myoblast differentiation culture medium and artificial fish tissue method |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115584341A (en) |
WO (1) | WO2024098467A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117511851A (en) * | 2024-01-03 | 2024-02-06 | 中国肉类食品综合研究中心 | Application of hydrogel scaffold in preparation of cell culture meat |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7033095B2 (en) * | 2019-03-04 | 2022-03-09 | 日清食品ホールディングス株式会社 | Three-dimensional muscle tissue and its manufacturing method |
CN112708591B (en) * | 2020-12-24 | 2022-04-29 | 南京周子未来食品科技有限公司 | Culture medium with definite chemical components for in-vitro differentiation of muscle stem cells |
CN114891733A (en) * | 2022-05-11 | 2022-08-12 | 上海食未生物科技有限公司 | A serum-free culture method for inducing muscle satellite cells to differentiate into myotubes |
-
2022
- 2022-11-07 CN CN202211387421.5A patent/CN115584341A/en active Pending
- 2022-11-23 WO PCT/CN2022/133749 patent/WO2024098467A1/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117511851A (en) * | 2024-01-03 | 2024-02-06 | 中国肉类食品综合研究中心 | Application of hydrogel scaffold in preparation of cell culture meat |
CN117511851B (en) * | 2024-01-03 | 2024-03-26 | 中国肉类食品综合研究中心 | Application of hydrogel scaffold in cell-cultured meat preparation |
Also Published As
Publication number | Publication date |
---|---|
WO2024098467A1 (en) | 2024-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | Tissue-like cultured fish fillets through a synthetic food pipeline | |
Ren et al. | Developments and opportunities for 3D bioprinted organoids | |
Jiang et al. | Enhancement of acellular cartilage matrix scaffold by Wharton's jelly mesenchymal stem cell-derived exosomes to promote osteochondral regeneration | |
AU2016204474B2 (en) | Engineered Comestible Meat | |
CN103298498B (en) | Ejection preparation for organ enhancing | |
CN110790950A (en) | Photo-crosslinking recombinant collagen hydrogel, preparation method and application thereof in 3D bioprinting | |
CN104189958B (en) | For promoting the preparation method of the multi-functional sticking patch of Properties of Chitosan Fibroin Blend albumen composite nano fiber of regenerating heart tissue and stem cell monitoring | |
CN107988158B (en) | A three-dimensional tumor model decellularized porous scaffold, construction method and application thereof | |
CN107164318B (en) | Method for constructing hollow vascularized heart based on 3D bioprinting technology and hollow vascularized heart | |
CN106039411A (en) | Method for preparing constructed body from biobrick containing oxidized alginate | |
Rao et al. | A review on directional muscle cell growth in scaffolding biomaterials with aligned porous structures for cultivated meat production | |
US20240074456A1 (en) | 3d-printable protein-enriched scaffolds | |
CN113215090A (en) | Manufacturing method of edible chitosan/sodium alginate/gelatin 3D scaffold for cell culture meat | |
JP7303865B2 (en) | Porous cell substrate containing vegetable protein and cultured meat produced using the same | |
Yuan et al. | Reciprocal interaction between vascular niche and sweat gland promotes sweat gland regeneration | |
EP4130235A1 (en) | Supporting bath for three-dimensional (3d) tissue culture | |
CN115584341A (en) | Fish myoblast differentiation culture medium and artificial fish tissue method | |
CN107029294A (en) | The method that a kind of the human adipose mesenchymal stem cells blend printed for three dimensional biological and three dimensional biological print body bone tissue | |
Wu et al. | Organoids in the oral and maxillofacial region: present and future | |
Ni et al. | Construction of vascularized tissue-engineered breast with dual angiogenic and adipogenic micro-tissues | |
Roy et al. | Engineering a sustainable protein revolution: recent advances in cultured meat production | |
CN108310463A (en) | 3D printing biological ink and preparation method thereof | |
Guan et al. | Engineered streaky pork by 3D co-printing and co-differentiation of muscle and fat cells | |
CN109182125A (en) | Three-dimensional single cell source cell ball production chip, preparation method and application | |
Singh et al. | In vitro meat-the start of new era in meat production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |